{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:07:22Z","timestamp":1778764042522,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hunan Provincial People\u2019s Hospital Foundation for Youths","award":["BSJJ202213"],"award-info":[{"award-number":["BSJJ202213"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02055-3","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:08:54Z","timestamp":1761653334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting syndecan-2 inhibits papillary thyroid cancer invasiveness and de-differentiation"],"prefix":"10.1186","volume":"25","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianhong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2055_CR1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0294","author":"L Lamartina","year":"2019","unstructured":"Lamartina L, Leboulleux S, Terroir M, Hartl D, Schlumberger M. An update on the management of low risk differentiated thyroid cancer. Endocr Relat Cancer. 2019. https:\/\/doi.org\/10.1530\/ERC-19-0294.","journal-title":"Endocr Relat Cancer"},{"key":"2055_CR2","doi-asserted-by":"crossref","unstructured":"Krajewska J, Kukulska A, Oczko-Wojciechowska M, Kotecka-Blicharz A, Drosik-Rutowicz K, Haras-Gil M et al. Early diagnosis of Low-Risk papillary thyroid cancer results rather in overtreatment than a better survival. Front Endocrinol (Lausanne). 2020;11.","DOI":"10.3389\/fendo.2020.571421"},{"key":"2055_CR3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1089\/thy.2020.0643","volume":"31","author":"A Toumi","year":"2021","unstructured":"Toumi A, DiGennaro C, Vahdat V, Jalali MS, Gazelle GS, Chhatwal J, et al. Trends in thyroid surgery and Guideline-Concordant care in the united States, 2007\u20132018. Thyroid. 2021;31:941\u20139.","journal-title":"Thyroid"},{"key":"2055_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00268-013-2224-1","volume":"38","author":"K Matsuzu","year":"2014","unstructured":"Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, et al. Thyroid lobectomy for papillary thyroid cancer: Long-term Follow-up study of 1,088 cases. World J Surg. 2014;38:68\u201379.","journal-title":"World J Surg"},{"key":"2055_CR5","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1210\/er.2019-00085","volume":"40","author":"DSA McLeod","year":"2019","unstructured":"McLeod DSA, Zhang L, Durante C, Cooper DS. Contemporary debates in adult papillary thyroid cancer management. Endocr Rev. 2019;40:1481\u201399.","journal-title":"Endocr Rev"},{"key":"2055_CR6","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn B-C. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics. 2021;11:6251\u201377.","journal-title":"Theranostics"},{"key":"2055_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13:644\u201360.","journal-title":"Nat Rev Endocrinol"},{"key":"2055_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1590\/2359-3997000000245","volume":"61","author":"A Schmidt","year":"2017","unstructured":"Schmidt A, Iglesias L, Klain M, Pitoia F, Schlumberger MJ. Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation. Arch Endocrinol Metab. 2017;61:81\u20139.","journal-title":"Arch Endocrinol Metab"},{"key":"2055_CR9","doi-asserted-by":"publisher","first-page":"19326","DOI":"10.1074\/jbc.M111.334730","volume":"287","author":"H Chung","year":"2012","unstructured":"Chung H, Lee J, Jeong D, Han I-O, Oh E-S. Melanocortin 1 receptor regulates melanoma cell migration by controlling Syndecan-2 expression. J Biol Chem. 2012;287:19326\u201335.","journal-title":"J Biol Chem"},{"key":"2055_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","volume":"15","author":"T Oh","year":"2013","unstructured":"Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, et al. Genome-Wide identification and validation of a novel methylation Biomarker, SDC2, for Blood-Based detection of colorectal cancer. J Mol Diagn. 2013;15:498\u2013507.","journal-title":"J Mol Diagn"},{"key":"2055_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1242\/jcs.113.7.1267","volume":"113","author":"F Granes","year":"2000","unstructured":"Granes F, Urena JM, Rocamora N, Vilaro S. Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci. 2000;113:1267\u201376.","journal-title":"J Cell Sci"},{"key":"2055_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0014-5793(03)00712-9","volume":"547","author":"F Granes","year":"2003","unstructured":"Granes F, Berndt C, Roy C, Mangeat P, Reina M, Vilaro S. Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain. FEBS Lett. 2003;547:212\u20136.","journal-title":"FEBS Lett"},{"key":"2055_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1034\/j.1600-0765.2002.01610.x","volume":"37","author":"W Worapamorn","year":"2002","unstructured":"Worapamorn W, Tam SP, Li H, Haase HR, Bartold PM. Cytokine regulation of syndecan-1 and-2 gene expression in human periodontal fibroblasts and osteoblasts. J Periodontal Res. 2002;37:273\u20138.","journal-title":"J Periodontal Res"},{"key":"2055_CR14","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1091\/mbc.e11-02-0099","volume":"22","author":"JR Whiteford","year":"2011","unstructured":"Whiteford JR, Xian X, Chaussade C, Vanhaesebroeck B, Nourshargh S, Couchman JR. Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell. 2011;22:3609\u201324.","journal-title":"Mol Biol Cell"},{"key":"2055_CR15","doi-asserted-by":"publisher","first-page":"35692","DOI":"10.1074\/jbc.M109.054254","volume":"284","author":"H-Y Ryu","year":"2009","unstructured":"Ryu H-Y, Lee J, Yang S, Park H, Choi S, Jung K-C, et al. Syndecan-2 functions as a Docking receptor for Pro-matrix Metalloproteinase-7 in human colon cancer cells. J Biol Chem. 2009;284:35692\u2013701.","journal-title":"J Biol Chem"},{"key":"2055_CR16","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.2147\/CMAR.S300861","volume":"13","author":"W Zhang","year":"2021","unstructured":"Zhang W, Yang C, Wang S, Xiang Z, Dou R, Lin Z, et al. SDC2 and TFPI2 methylation in stool samples as an integrated biomarker for early detection of colorectal cancer. Cancer Manag Res. 2021;13:3601\u201317.","journal-title":"Cancer Manag Res"},{"key":"2055_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-4598-11-19","volume":"11","author":"T De Oliveira","year":"2012","unstructured":"De Oliveira T, Abiatari I, Raulefs S, Sauliunaite D, Erkan M, Kong B, et al. Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype. Mol Cancer. 2012;11:19.","journal-title":"Mol Cancer"},{"key":"2055_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wei X, Pan Y, Xu J, Si Y, Min Z, et al. A new risk factor indicator for papillary thyroid cancer based on immune infiltration. Cell Death Dis. 2021;12:51.","journal-title":"Cell Death Dis"},{"key":"2055_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12935-020-01283-y","volume":"20","author":"X Wang","year":"2020","unstructured":"Wang X, Fu X, Zhang J, Xiong C, Zhang S, Lv Y. Identification and validation of m6A RNA methylation regulators with clinical prognostic value in papillary thyroid cancer. Cancer Cell Int. 2020;20:203.","journal-title":"Cancer Cell Int"},{"key":"2055_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"N Agrawal","year":"2014","unstructured":"Agrawal N, Akbani R, Aksoy BA, Ally A, Arachchi H, Asa SL, et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676\u201390.","journal-title":"Cell"},{"key":"2055_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.2012.302","volume":"107","author":"G Dom","year":"2012","unstructured":"Dom G, Tarabichi M, Unger K, Thomas G, Oczko-Wojciechowska M, Bogdanova T, et al. A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer. 2012;107:994\u20131000.","journal-title":"Br J Cancer"},{"key":"2055_CR22","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"2055_CR23","doi-asserted-by":"publisher","first-page":"eaay5947","DOI":"10.1126\/science.aay5947","volume":"367","author":"E Sj\u00f6stedt","year":"2020","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367:eaay5947.","journal-title":"Science"},{"key":"2055_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:956\u201363. Database issue:D.","journal-title":"Nucleic Acids Res"},{"key":"2055_CR25","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and apis. Nucleic Acids Res. 2019;47:W199\u2013205.","journal-title":"Nucleic Acids Res"},{"key":"2055_CR26","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M","volume":"73","author":"N Fabien","year":"1994","unstructured":"Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM, Paulin C. Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer. 1994;73:2206\u201312.","journal-title":"Cancer"},{"key":"2055_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4836","author":"R Liu","year":"2022","unstructured":"Liu R, Cao Z, Pan M, Wu M, Li X, Yuan H, et al. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes. Cancer Med. 2022. https:\/\/doi.org\/10.1002\/cam4.4836.","journal-title":"Cancer Med"},{"key":"2055_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/jmcb\/mjw007","volume":"8","author":"M Esmaeili","year":"2016","unstructured":"Esmaeili M, Jennek S, Ludwig S, Klitzsch A, Kraft F, Melle C, et al. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells. J Mol Cell Biol. 2016;8:207\u201320.","journal-title":"J Mol Cell Biol"},{"key":"2055_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12885-016-2200-x","volume":"16","author":"MM Alam","year":"2016","unstructured":"Alam MM, Sohoni S, Kalainayakan SP, Garrossian M, Zhang L. Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells. BMC Cancer. 2016;16:150.","journal-title":"BMC Cancer"},{"key":"2055_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Peng W, Li C, Qin R, Zhong Z, Sun C. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells. Cancer Cell Int. 2021;21:231.","journal-title":"Cancer Cell Int"},{"key":"2055_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/thy.2018.0601","volume":"30","author":"CS Fuziwara","year":"2020","unstructured":"Fuziwara CS, Saito KC, Kimura ET. Thyroid follicular cell loss of differentiation induced by MicroRNA miR-17-92 cluster is attenuated by CRISPR\/Cas9n gene Silencing in anaplastic thyroid cancer. Thyroid. 2020;30:81\u201394.","journal-title":"Thyroid"},{"key":"2055_CR32","first-page":"1847","volume":"8","author":"J Song","year":"2018","unstructured":"Song J, Qiu W, Deng X, Qiu Z, Fan Y, Yang Z. A somatic mutation of RasGRP3 decreases Na+\/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway. Am J Cancer Res. 2018;8:1847\u201355.","journal-title":"Am J Cancer Res"},{"key":"2055_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2407-5-80","volume":"5","author":"I Presta","year":"2005","unstructured":"Presta I, Arturi F, Ferretti E, Mattei T, Scarpelli D, Tosi E, et al. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene. BMC Cancer. 2005;5:80.","journal-title":"BMC Cancer"},{"key":"2055_CR34","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.3390\/jcm7040061","volume":"7","author":"S W\u00e4chter","year":"2018","unstructured":"W\u00e4chter S, Damanakis AI, Elxnat M, Roth S, Wunderlich A, Verburg FA, et al. Epigenetic modifications in thyroid cancer cells restore NIS and Radio-Iodine uptake and promote cell death. J Clin Med. 2018;7:E61.","journal-title":"J Clin Med"},{"key":"2055_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14728222.2011.553607","volume":"15","author":"M Dentice","year":"2011","unstructured":"Dentice M. Hedgehog-mediated regulation of thyroid hormone action through Iodothyronine deiodinases. Expert Opin Ther Targets. 2011;15:493\u2013504.","journal-title":"Expert Opin Ther Targets"},{"key":"2055_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/cancers13030418","volume":"13","author":"Y Lu","year":"2021","unstructured":"Lu Y, Zhu Y, Deng S, Chen Y, Li W, Sun J, et al. Targeting the Sonic Hedgehog pathway to suppress the expression of the cancer stem cell (CSC)-Related transcription factors and CSC-Driven thyroid tumor growth. Cancers (Basel). 2021;13:418.","journal-title":"Cancers (Basel)"},{"key":"2055_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.surg.2019.09.010","volume":"167","author":"CE Barrows","year":"2020","unstructured":"Barrows CE, Belle JM, Fleishman A, Lubitz CC, James BC. Financial burden of thyroid cancer in the united states: an estimate of economic and psychological hardship among thyroid cancer survivors. Surgery. 2020;167:378\u201384.","journal-title":"Surgery"},{"key":"2055_CR38","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.2147\/CMAR.S248374","volume":"12","author":"G-M Fu","year":"2020","unstructured":"Fu G-M, Wang Z-H, Chen Y-B, Li C-H, Zhang Y-J, Li X-J, et al. Analysis of risk factors for lymph node metastases in elderly patients with papillary thyroid Micro-Carcinoma. Cancer Manag Res. 2020;12:7143\u20139.","journal-title":"Cancer Manag Res"},{"key":"2055_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12893-020-00974-7","volume":"20","author":"F Li","year":"2020","unstructured":"Li F, Pan D, He Y, Wu Y, Peng J, Li J, et al. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer. BMC Surg. 2020;20:315.","journal-title":"BMC Surg"},{"key":"2055_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133.","journal-title":"Thyroid"},{"key":"2055_CR41","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1242\/dev.031492","volume":"136","author":"CB Arrington","year":"2009","unstructured":"Arrington CB, Yost HJ. Extra-embryonic syndecan 2 regulates organ primordia migration and fibrillogenesis throughout the zebrafish embryo. Development. 2009;136:3143\u201352.","journal-title":"Development"},{"key":"2055_CR42","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12935-017-0470-2","volume":"17","author":"F Zhao","year":"2017","unstructured":"Zhao F, Pu Y, Cui M, Wang H, Cai S. MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene. Cancer Cell Int. 2017;17:100.","journal-title":"Cancer Cell Int"},{"key":"2055_CR43","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1038\/onc.2013.328","volume":"33","author":"M Sun","year":"2014","unstructured":"Sun M, Gomes S, Chen P, Frankenberger CA, Sankarasharma D, Chung CH, et al. RKIP and HMGA2 regulate breast tumor survival and metastasis through Lysyl oxidase and syndecan-2. Oncogene. 2014;33:3528\u201337.","journal-title":"Oncogene"},{"key":"2055_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","volume":"11","author":"YD Han","year":"2019","unstructured":"Han YD, Oh TJ, Chung T-H, Jang HW, Kim YN, An S, et al. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clin Epigenetics. 2019;11:51.","journal-title":"Clin Epigenetics"},{"key":"2055_CR45","doi-asserted-by":"publisher","first-page":"6752141","DOI":"10.1155\/2021\/6752141","volume":"2021","author":"B-Y Nan","year":"2021","unstructured":"Nan B-Y, Xiong G-F, Zhao Z-R, Gu X, Huang X-S. Comprehensive identification of potential crucial genes and miRNA-mRNA regulatory networks in papillary thyroid cancer. Biomed Res Int. 2021;2021:6752141.","journal-title":"Biomed Res Int"},{"key":"2055_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fendo.2020.00467","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Y, Li X, Wang Y, Wu K, Wu J, et al. Identification of a recurrence signature and validation of cell infiltration level of thyroid cancer microenvironment. Front Endocrinol (Lausanne). 2020;11:467.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2055_CR47","doi-asserted-by":"publisher","first-page":"e1092","DOI":"10.1038\/cddis.2014.32","volume":"5","author":"X Meng","year":"2014","unstructured":"Meng X, Kong D-H, Li N, Zong Z-H, Liu B-Q, Du Z-X, et al. Knockdown of BAG3 induces epithelial\u2013mesenchymal transition in thyroid cancer cells through ZEB1 activation. Cell Death Dis. 2014;5:e1092.","journal-title":"Cell Death Dis"},{"key":"2055_CR48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fonc.2020.00404","volume":"10","author":"H Shang","year":"2020","unstructured":"Shang H, Zhao J, Yao J, Wang H, Dong J, Liao L. Nevirapine increases Sodium\/Iodide Symporter-Mediated Radioiodide uptake by activation of TSHR\/cAMP\/CREB\/PAX8 signaling pathway in dedifferentiated thyroid cancer. Front Oncol. 2020;10:404.","journal-title":"Front Oncol"},{"key":"2055_CR49","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1210\/jc.2009-1888","volume":"95","author":"P Hou","year":"2010","unstructured":"Hou P, Bojdani E, Xing M. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways. J Clin Endocrinol Metab. 2010;95:820\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2055_CR50","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1210\/jc.2015-3433","volume":"101","author":"W Cheng","year":"2016","unstructured":"Cheng W, Liu R, Zhu G, Wang H, Xing M. Robust thyroid gene expression and radioiodine uptake induced by simultaneous suppression of BRAF V600E and histone deacetylase in thyroid cancer cells. J Clin Endocrinol Metab. 2016;101:962\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2055_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00656-0","author":"Y Liao","year":"2020","unstructured":"Liao Y, Hua Y, Li Y, Zhang C, Yu W, Guo P, et al. CRSP8 promotes thyroid cancer progression by antagonizing IKK\u03b1-induced cell differentiation. Cell Death Differ. 2020. https:\/\/doi.org\/10.1038\/s41418-020-00656-0.","journal-title":"Cell Death Differ"},{"key":"2055_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.canlet.2015.07.012","volume":"380","author":"A Husain","year":"2016","unstructured":"Husain A, Hu N, Sadow PM, Nucera C. Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(v600E). Cancer Lett. 2016;380:577\u201385.","journal-title":"Cancer Lett"},{"key":"2055_CR53","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2147\/OTT.S128564","volume":"10","author":"D Su","year":"2017","unstructured":"Su D, Liu Y, Song T. Knockdown of IQGAPI inhibits proliferation and epithelial-mesenchymal transition by Wnt\/beta-catenin pathway in thyroid cancer. Oncotargets Therapy. 2017;10:1549\u201359.","journal-title":"Oncotargets Therapy"},{"key":"2055_CR54","first-page":"560","volume":"8","author":"CW Jung","year":"2015","unstructured":"Jung CW, Han KH, Seol H, Park S, Koh JS, Lee S-S, et al. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma. Int J Clin Exp Pathol. 2015;8:560\u20138.","journal-title":"Int J Clin Exp Pathol"},{"key":"2055_CR55","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.surg.2010.07.030","volume":"148","author":"KK Nelson","year":"2010","unstructured":"Nelson KK, Gattuso P, Xu X, Prinz RA. Expression of the Sonic Hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy. Surgery. 2010;148:654\u201360. discussion 660.","journal-title":"Surgery"},{"key":"2055_CR56","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2353\/ajpath.2009.080623","volume":"174","author":"YM Schrage","year":"2009","unstructured":"Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen A-M, Taminiau AHM, Hogendoorn PCW, et al. Aberrant Heparan sulfate proteoglycan Localization, despite normal Exostosin, in central chondrosarcoma. Am J Pathol. 2009;174:979\u201388.","journal-title":"Am J Pathol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02055-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:05:23Z","timestamp":1761656723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2055"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02055-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by ethics committee of Hunan Provincial People\u2019s Hospital (No.2022-P-117).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}